High index of suspicion for early diagnosis of alendronate-induced stage zero osteonecrosis of jaw in thalassaemia major

British Journal of Haematology

Volumn 166, Issue 2, 2014, Pages 292-294

  Chatterjee, Ratna ^a   Bajoria, Rekha ^a   Shah, Farrukh T ^b   Porter, John B ^b   Fedele, Stefano ^c  

^a DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alendronate; Bisphosphonate induced osteonecrosis of jaw; Thalassaemia major

Indexed keywords

ALENDRONIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; DEFEROXAMINE; PAMIDRONIC ACID;

ADULT; BONE DISEASE; BONE NECROSIS; BONE PAIN; BONE REMODELING; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY DIAGNOSIS; ETHNICITY; FEMALE; GINGIVA PAIN; HUMAN; INFECTION; IRON OVERLOAD; JAW OSTEONECROSIS; JAW PAIN; LETTER; MALE; MIDDLE AGED; OSTEOLYSIS; OSTEOPENIA OSTEOPOROSIS SYNDROME; PRIORITY JOURNAL; THALASSEMIA MAJOR; TOOTH EXTRACTION; TREATMENT DURATION;

ALENDRONATE; BISPHOSPHONATE INDUCED OSTEONECROSIS OF JAW; THALASSAEMIA MAJOR;

ALENDRONATE; BETA-THALASSEMIA; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 84903709809     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12833     Document Type: Letter

References (10)

1. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws and American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. Journal of Oral and Maxillofacial Surgery, 65, 369-376.
2. Assael, L.A. (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. Journal of Oral and Maxillofacial Surgery, 67, 35-43.
3. Benlidayi, C. & Guzel, R. (2013) Oral bisphosphonate related osteonecrosis of the jaw: a challenging adverse effect. ISRN Rheumatology, 2013, 215034-215040.
4. Chatterjee, R., Shah, F.S., Davis, B.A., Byers, M., Sooranna, S., Bajoria, R., Pringle, J. & Porter, J.B. (2012) Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome. British Journal of Haematology, 159, 462-471.
5. Fedele, S., Porter, S.R., D'Aiuto, F., Aljohani, S., Vescovi, P., Manfredi, M., Arduino, P.G., Broccoletti, R., Musciotto, A., Di Fede, O., Lazarovici, T.S., Campisi, G. & Yarom, N. (2010) Non exposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. American Journal of Medicine, 123, 1060-1064.
6. Koka, S., Clarke, B.L., Amin, S., Gertz, M. & Ruggiero, S.L. (2007) Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient. The International Journal of Prosthodontics, 20, 115-122.
7. Kühl, S., Walter, C., Acham, S., Pfeffer, R. & Lambrecht, J.T. (2012) Bisphosphonate-related osteonecrosis of the jaws-a review. Oral Oncology, 48, 938-947.
8. Marx, R.E. (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of Oral and Maxillofacial Surgery, 61, 1115-1117.
9. Otto, S., Schreyer, C., Hafner, S., Mast, G., Ehrenfeld, M., Stürzenbaum, S. & Pautke, C. (2012) Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. Journal of Cranio-Maxillo-Facial Surgery, 40, 303-309.
10. Terpos, E. & Voskaridou, E. (2010) Treatment options for thalassemia patients with osteoporosis. Annals of the New York Academy of Sciences, 1202, 237-243.